| 摘要 |
<p>The present invention relates to a combination of one or more nucleic acids encoding, (a) in a first open reading frame (i) a promoter, (ii) an amyloid peptide, (iii) a cell surface targeting signal, (iv) a transmembrane anchoring domain and (b) in a second open reading frame (i) a group specific antigen (gag). Also the invention relates to a pharmaceutical composition and a vaccine comprising A²-retroparticles.</p> |
